Skip to main content

ADVERTISEMENT

Amber Denham

News
07/02/2024
A retrospective analysis demonstrated that post-transplantation cyclophosphamide yielded survival and non-relapse mortality benefit compared to anti-thymocyte globulin treatment for GVHD prophylaxis among patients undergoing allogeneic stem...
A retrospective analysis demonstrated that post-transplantation cyclophosphamide yielded survival and non-relapse mortality benefit compared to anti-thymocyte globulin treatment for GVHD prophylaxis among patients undergoing allogeneic stem...
A retrospective analysis...
07/02/2024
Oncology